5-HT receptors expressed throughout the human body are targets for established
therapeutics and various drugs in development. Their diversity of structure and function …

The existence of an endogenous vasoconstrictor in blood serum (Stevens and Lee, 1984;
Brodie, 1900) and the presence in the gut of a substance that increases intestinal motility …

Objective: To correlate the location of stroke with poststroke depression (PSD) and
emotional incontinence (PSEI). Methods: The authors prospectively studied 148 patients (94 …

The serotonin (5-HT) 1B receptor is expressed in the central nervous system (CNS) of
rodents and its homologous 5-HT1Dβ receptor is expressed in human. These receptors are …

The 5-hydroxytryptamine 1B receptor is a serotonin receptor subtype which is expressed
predominantly in the basal ganglia. It has been suggested to play a role in movement and …

The regional distribution and the pharmacology of the binding sites labelled with the novel 5-
hydroxytryptamine (serotonin) 5-HT 1B/1D selective radioligand serotonin-O-carboxy-methyl …

As the pharmacological community moves towards obtaining a consensus on the criteria
used to systematically ctassify receptors and ion channeW it has become clear that …

In the last few years, molecular biology has led to the cloning and characterization of several
5-HT receptors (serotonin receptors) in vertebrates and in invertebrates. These studies have …

The effects of drugs on the central and peripheral nervous systems can be easily recognized
in normal animals. This does not necessarily mean that these effects can be used in therapy …

We report on the autoradiographic distribution of 5-HT1B, 5-HT1D and 5-HT1F receptor
subtypes in human brain, focusing on the brainstem and cervical spinal cord. We have used …